241 related articles for article (PubMed ID: 16262559)
1. Emerging drugs for idiopathic pulmonary fibrosis.
Thannickal VJ; Flaherty KR; Hyzy RC; Lynch JP
Expert Opin Emerg Drugs; 2005 Nov; 10(4):707-27. PubMed ID: 16262559
[TBL] [Abstract][Full Text] [Related]
2. New developments in the therapy of pulmonary fibrosis.
Scriabine A; Rabin DU
Adv Pharmacol; 2009; 57():419-64. PubMed ID: 20230768
[TBL] [Abstract][Full Text] [Related]
3. Treatment of idiopathic pulmonary fibrosis: is there anything new?
Abdelaziz MM; Samman YS; Wali SO; Hamad MM
Respirology; 2005 Jun; 10(3):284-9. PubMed ID: 15955138
[TBL] [Abstract][Full Text] [Related]
4. [Recent advances on the role of chemokines/chemokine receptors in the pathogenesis of idiopathic pulmonary fibrosis].
Brunetti G; Pignatti P
Recenti Prog Med; 2007 Feb; 98(2):90-6. PubMed ID: 17439069
[TBL] [Abstract][Full Text] [Related]
5. New pharmacological strategies for the treatment of pulmonary fibrosis.
Gogali A; Wells AU
Ther Adv Respir Dis; 2010 Dec; 4(6):353-66. PubMed ID: 20864457
[TBL] [Abstract][Full Text] [Related]
6. Medical treatment for pulmonary fibrosis: current trends, concepts, and prospects.
Brown KK; Raghu G
Clin Chest Med; 2004 Dec; 25(4):759-72, vii. PubMed ID: 15564021
[TBL] [Abstract][Full Text] [Related]
7. Emerging drugs for adult acute lymphoblastic leukaemia.
Thomas X
Expert Opin Emerg Drugs; 2005 Aug; 10(3):591-617. PubMed ID: 16083331
[TBL] [Abstract][Full Text] [Related]
8. [Idiopathic pulmonary fibrosis].
Doubková M; Skhicková J
Vnitr Lek; 2005 Dec; 51(12):1375-84. PubMed ID: 16430105
[TBL] [Abstract][Full Text] [Related]
9. [Idiopathic pulmonary fibrosis (IPF)].
Matsumoto A; Azuma A
Nihon Rinsho; 2006 Jul; 64(7):1354-60. PubMed ID: 16838656
[TBL] [Abstract][Full Text] [Related]
10. Current and future therapeutic approaches in idiopathic pulmonary fibrosis.
Bouros D; Antoniou KM
Eur Respir J; 2005 Oct; 26(4):693-702. PubMed ID: 16204603
[TBL] [Abstract][Full Text] [Related]
11. The evolving pharmacotherapy of pulmonary fibrosis.
Lota HK; Wells AU
Expert Opin Pharmacother; 2013 Jan; 14(1):79-89. PubMed ID: 23265249
[TBL] [Abstract][Full Text] [Related]
12. Idiopathic pulmonary fibrosis.
Balamugesh T; Behera D
J Assoc Physicians India; 2007 May; 55():363-70. PubMed ID: 17844698
[TBL] [Abstract][Full Text] [Related]
13. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
14. Therapies for interstitial lung disease: past, present and future.
Kim R; Meyer KC
Ther Adv Respir Dis; 2008 Oct; 2(5):319-38. PubMed ID: 19124380
[TBL] [Abstract][Full Text] [Related]
15. Role of integrin-mediated TGFbeta activation in the pathogenesis of pulmonary fibrosis.
Goodwin A; Jenkins G
Biochem Soc Trans; 2009 Aug; 37(Pt 4):849-54. PubMed ID: 19614606
[TBL] [Abstract][Full Text] [Related]
16. Interferon gamma-1b in the treatment of idiopathic pulmonary fibrosis.
Pacanowski MA; Amsden GW
Ann Pharmacother; 2005 Oct; 39(10):1678-86. PubMed ID: 16160001
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic pulmonary fibrosis: new insights into pathogenesis.
Noble PW; Homer RJ
Clin Chest Med; 2004 Dec; 25(4):749-58, vii. PubMed ID: 15564020
[TBL] [Abstract][Full Text] [Related]
18. Emerging drugs for the treatment of myelodysplastic syndrome.
Nivatpumin PJ; Gore SD
Expert Opin Emerg Drugs; 2005 Aug; 10(3):569-90. PubMed ID: 16083330
[TBL] [Abstract][Full Text] [Related]
19. Host-environment interactions in pulmonary fibrosis.
Garantziotis S; Schwartz DA
Semin Respir Crit Care Med; 2006 Dec; 27(6):574-80. PubMed ID: 17195134
[TBL] [Abstract][Full Text] [Related]
20. Pirfenidone for the treatment of idiopathic pulmonary fibrosis.
Antoniu SA
Expert Opin Investig Drugs; 2006 Jul; 15(7):823-8. PubMed ID: 16787145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
